Sort
11,323 grants matching “glioblastoma”
Astrocytic Cancers: How, When, Where?
$1,087,426Terry A Van Dyke · Univ Of North Carolina Chapel Hill · U01 · FY2007 · CA
Astrocytic Cancers: How, When, Where?
$1,087,330Terry A Van Dyke · Univ Of North Carolina Chapel Hill · U01 · FY2006 · CA
Novel Technologies to Isolate and Analyze Extrachromosomal DNAs for Diagnostic Applications
$1,084,044Massa J. Shoura · Phinomics Inc. · R44 · FY2025 · GM
Astrocytic Cancers: How, When, Where?
$1,080,550University Of North Carolina Chapel Hill · U01 · FY2005 · CA
DCTD Screening Technologies
$1,080,000Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA
Design and Utility of Novel Proteinaceous Biomaterials
$1,079,293Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases
$1,079,030Sankar Adhya · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Isolation, characterization and translational development of glioma stem cells
$1,077,600Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Isolation, characterization and translational development of glioma stem cells
$1,077,600Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2020 · CA
iPS cell based immunotherapy for malignant gliomas
$1,073,572John Park · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Sphingolipids in Cancer Therapy and Angiogenesis
$1,071,665Yusuf Awni Hannun · Medical University Of South Carolina · P01 · FY2007 · CA
Development and Expansion of the Human Cerebral Cortex
$1,071,206Arnold Kriegstein · University Of California, San Francisco · R35 · FY2023 · NS
Molecular Mechanism of TNF Signaling and Apoptosis
$1,068,246Zheng-Gang Liu · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
$1,065,881Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CDK3-inhibiting anticancer agents
$1,064,678Donald C. Porter · Senex Biotechnology, Inc. · R44 · FY2011 · CA
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
$1,062,215Martin Carroll · University Of Pennsylvania · U54 · FY2025 · CA
Isolation, characterization and translational development of glioma stem cells
$1,056,048Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Isolation, characterization and translational development of glioma stem cells
$1,056,048Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
$1,051,862John Anthony Muraski · Endurx Pharmaceuticals, Inc. · R44 · FY2015 · CA
Role of histone variants in aging and cancer
$1,049,760Yamini P Dalal · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasma
$1,049,684Robert J Coffey · Vanderbilt University Medical Center · UH3 · FY2022 · CA
Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasma
$1,049,684Robert J Coffey · Vanderbilt University Medical Center · UH3 · FY2021 · CA
Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis
$1,046,405Myriam Gorospe · National Institute On Aging · ZIA · FY2016 · AG
Isolation, characterization and translational development of glioma stem cells
$1,045,270Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2019 · CA
Molecular Pathogenesis of Neoplasia
$1,040,298John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS